It is better described as a natural metabolic support than a natural version of a weight-loss drug
2: Reduction in Certain Diseases Recent clinical trial results suggest that the health impacts of GLP-1RAs go beyond weight loss, with the drug leading to a reduction in various diseases, such as cardiovascular disease or slowing down the progression of some illnesses such as chronic kidney disease
Hope DCD, Hinds CE, Lopes T, Vincent ML, Shrewsbury JV, Yu ATC, et al
Increased fluid intake may be needed if experiencing nausea, vomiting, or diarrhea, as dehydration frequently underlies headaches in patients taking these medications
Anti-diabetic medication (ADM) prescribing rates in December 2024 were similar to those in September 2024 (-0.88%)
Bhuyan says